Millennium Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,465
| Closed | -$290K | – | 6881 |
|
|
2023
Q4 | $290K | Buy |
25,465
+14,790
| +139% | +$116K | ﹤0.01% | 4977 |
|
|
2023
Q3 | $43K | Sell |
10,675
-5,945
| -36% | -$44.1K | ﹤0.01% | 5514 |
|
|
2023
Q2 | $118K | Sell |
16,620
-48,662
| -75% | -$337K | ﹤0.01% | 5287 |
|
|
2023
Q1 | $486K | Sell |
65,282
-58,347
| -47% | -$491K | ﹤0.01% | 4620 |
|
|
2022
Q4 | $897K | Buy |
123,629
+55,512
| +81% | +$468K | ﹤0.01% | 4272 |
|
|
2022
Q3 | $661K | Buy |
68,117
+10,125
| +17% | +$189K | ﹤0.01% | 4713 |
|
|
2022
Q2 | $1.11M | Buy |
57,992
+56,205
| +3,145% | +$1.46M | ﹤0.01% | 4271 |
|
|
2022
Q1 | $89K | Sell |
1,787
-8,391
| -82% | -$435K | ﹤0.01% | 6200 |
|
|
2021
Q4 | $768K | Sell |
10,178
-50,097
| -83% | -$3.42M | ﹤0.01% | 4657 |
|
|
2021
Q3 | $4.76M | Buy |
60,275
+58,959
| +4,480% | +$5.93M | ﹤0.01% | 2917 |
|
|
2021
Q2 | $183K | Sell |
1,316
-1,486
| -53% | -$283K | ﹤0.01% | 6055 |
|
|
2021
Q1 | $586K | Sell |
2,802
-15,319
| -85% | -$3.07M | ﹤0.01% | 4691 |
|
|
2020
Q4 | $3.01M | Buy |
+18,121
| New | +$2.8M | ﹤0.01% | 2895 |
|
|
2020
Q3 | – | Sell |
-19,967
| Closed | -$3.32M | – | 4936 |
|
|
2020
Q2 | $3.32M | Buy |
19,967
+11,773
| +144% | +$1.84M | ﹤0.01% | 2132 |
|
|
2020
Q1 | $949K | Buy |
8,194
+92
| +1% | +$12.9K | ﹤0.01% | 2500 |
|
|
2019
Q4 | $1.2M | Buy |
+8,102
| New | +$1.23M | ﹤0.01% | 2920 |
|
|
2019
Q3 | – | Sell |
-1,593
| Closed | -$207K | – | 4659 |
|
|
2019
Q2 | $207K | Sell |
1,593
-11,073
| -87% | -$1.29M | ﹤0.01% | 3744 |
|
|
2019
Q1 | $1.2M | Buy |
+12,666
| New | +$1.66M | ﹤0.01% | 2754 |
|
Millennium Management's HARP Position: Q1 2024 in Review
Millennium Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 25,465 shares — an estimated $290K sold.
Millennium Management first reported a position in HARP in Q1 2019 and held it in 18 quarters. The position peaked at $4.76M in Q3 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- Millennium Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 25,465 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $290K.
- Millennium Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 18 quarters.
- Millennium Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.76M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.